Showing Results for
- Academic Journals (17)
Search Results
- 17
Academic Journals
- 17
- Search Terms:
- 1From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground Patients who receive highly variable doses of warfarin may be at risk for poor anticoagulation control and adverse events. However, we lack a system to identify patients with the highest dose variability....
- 2From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground Factor V (FV) in its activated form, FVa, is a critical regulator of thrombin generation during fibrin clot formation. There is a need of a simple, fast, and inexpensive microplate-based coagulation assay...
- 3From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground Elastin microfibril interface located protein 2 (EMILIN2) is an extracellular glycoprotein associated with cardiovascular development. While other EMILIN proteins are reported to play a role in...
- 4From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground To assess the incidence of venous thromboembolism (VTE) and bleeding events with or without thromboprophylaxis and the associated costs in a cohort of medically ill patients in both in-hospital and...
- 5From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground Different platelet function tests can be used to evaluate the degree of achieved platelet inhibition in patients treated with clopidogrel. The presence of CYP 2C19*2 polymorphism can reduce the formation...
- 6From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground Cirrhotic patients are characterized by a decreased synthesis of coagulation and anticoagulation factors. The coagulopathy of cirrhotic patients is considered to be auto-anticoagulation. Our aim was to...
- 7From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground Mature carotid plaques are complex structures, and their histological classification is challenging. The carotid plaques of asymptomatic and symptomatic patients could exhibit identical histological...
- 8From: Thrombosis Journal. (Vol. 9) Peer-ReviewedWe report a case of near fatal aortic thrombosis in a trauma patient homozygous for mutation of Factor V Leiden. He responded well to vascular surgery and intensive care unit management and was discharged successfully...
- 9From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground Venous thromboembolism (VTE) is a major health and financial burden. VTE impacts health outcomes in surgical and non-surgical patients. VTE prophylaxis is underutilized, particularly amongst high risk...
- 10From: Thrombosis Journal. (Vol. 9) Peer-ReviewedIn European countries, low-molecular-weight heparin is generally initiated preoperatively for thromboprophylaxis in hip or knee replacement surgery. The objective of this review is to compare pre- and postoperative...
- 11From: Thrombosis Journal. (Vol. 9) Peer-ReviewedRecent literature reports an increased incidence of venous thrombosis following thalidomide use in the treatment of diseases with disease-related thrombotic risks such as malignancy, as well as concomitant use with...
- 12From: Thrombosis Journal. (Vol. 9) Peer-Reviewed
Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time
Simultaneous or sequential haemorrhage and thrombosis in the presence of a prolonged activated partial thromboplastin time (aPTT) is a rare occurrence: we describe the case a 37 year old lady who developed post-delivery... - 13From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground The ergotamine tartrate associated with certain categories of drugs can lead to critical ischemia of the extremities. Discontinuation of taking ergotamine is usually sufficient for the total regression of...
- 14From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground The prevention of venous thromboembolism has been identified as a leading priority in hospital safety. Recommended parenteral anticoagulant agents with different indications for the prevention and...
- 15From: Thrombosis Journal. (Vol. 9) Peer-ReviewedWarfarin has a long history of benefit and has become the gold standard medication for the prevention of ischemic stroke in patients with atrial fibrillation. Nevertheless, it is far from perfect and there is no doubt...
- 16From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground Venous thromboembolism prophylaxis has been shown to safely and cost-effectively reduce the incidence of thromboembolic events in medical inpatients. However, there is a gap between evidence and medical...
- 17From: Thrombosis Journal. (Vol. 9) Peer-ReviewedBackground Patients undergoing elective total hip replacement (THR) surgery are at an increased risk for venous thromboembolic events (VTEs). Dalteparin and enoxaparin are recommended as thromboprophylaxis for at...